{"name":"Cibiem","permalink":"cibiem","crunchbase_url":"http://www.crunchbase.com/company/cibiem","homepage_url":"http://www.cibiem.com/","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"","alias_list":"","email_address":"","phone_number":"212-929-6600","description":"A medical device company","created_at":"Thu Oct 18 12:41:46 UTC 2012","updated_at":"Thu Oct 18 12:45:47 UTC 2012","overview":"<p>Cibiem is a medical device company leveraging its proprietary, minimally invasive, catheter-based approach focused on Carotid Body Modulationâ„¢ (CBM) for the treatment of sympathetic nervous system-mediated diseases such as hypertension, heart failure, diabetes and renal failure. The company was co-founded by Mark Gelfand and Howard R. Levin, M.D., the proven team of innovators and entrepreneurs behind Coridea. The company is backed by top-tier venture investors Third Rock Ventures and SV Life Sciences.</p>","image":{"available_sizes":[[[150,55],"assets/images/resized/0021/6153/216153v1-max-150x150.jpg"],[[250,91],"assets/images/resized/0021/6153/216153v1-max-250x250.jpg"],[[261,96],"assets/images/resized/0021/6153/216153v1-max-450x450.jpg"]],"attribution":null},"products":[],"relationships":[],"competitions":[],"providerships":[],"total_money_raised":"$10M","funding_rounds":[{"round_code":"a","source_url":"http://www.finsmes.com/2012/10/cibiem-raises-10m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Cibiem Raises $10M in Series A Financing","raised_amount":10000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":10,"funded_day":17,"investments":[{"company":null,"financial_org":{"name":"SV Life Sciences","permalink":"sv-life-sciences","image":{"available_sizes":[[[150,70],"assets/images/resized/0004/5361/45361v1-max-150x150.jpg"],[[250,117],"assets/images/resized/0004/5361/45361v1-max-250x250.jpg"],[[267,125],"assets/images/resized/0004/5361/45361v1-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Third Rock Ventures","permalink":"third-rock-ventures-2","image":{"available_sizes":[[[150,78],"assets/images/resized/0005/0700/50700v1-max-150x150.png"],[[205,107],"assets/images/resized/0005/0700/50700v1-max-250x250.png"],[[205,107],"assets/images/resized/0005/0700/50700v1-max-450x450.png"]],"attribution":null}},"person":null}]}],"investments":[],"acquisition":null,"acquisitions":[],"offices":[{"description":"","address1":"134 West 26th Street","address2":"Suite 1011","zip_code":"10001","city":"New York","state_code":"NY","country_code":"USA","latitude":null,"longitude":null}],"milestones":[],"ipo":null,"video_embeds":[],"screenshots":[{"available_sizes":[[[150,109],"assets/images/resized/0021/6154/216154v1-max-150x150.jpg"],[[250,182],"assets/images/resized/0021/6154/216154v1-max-250x250.jpg"],[[450,328],"assets/images/resized/0021/6154/216154v1-max-450x450.jpg"]],"attribution":null}],"external_links":[]}